![]() AEON Biopharma AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology. | ||
Founding Date | Founding Date 2012 | Founding Date 2017 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Irvine, US HQ Newport Beach, US | Locations San Carlos, US HQ |
Employees | Employees 6 | Employees 13 |
Funding | ||
Total funding raised | Total funding raised $ 112.6m | Total funding raised $ 12.7m |

Cage Bio is a biotechnology company developing an ionic liquid platform.
View company